Literature DB >> 9616201

High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection.

J M McCune1, R Loftus, D K Schmidt, P Carroll, D Webster, L B Swor-Yim, I R Francis, B H Gross, R M Grant.   

Abstract

The thymus in adults infected with the HIV-1 is generally thought to be inactive, both because of age-related involution and viral destruction. We have revisited the question of thymic function in adults, using chest-computed tomography (CT) to measure thymic tissue in HIV-1-seropositive (n = 99) or HIV-1-seronegative (n = 32) subjects, and correlating these results with the level of circulating CD4(+) and CD8(+) T cells that are phenotypically described as naive thymic emigrants. Abundant thymic tissue was detectable in many (47/99) HIV-1-seropositive adults, aged 20-59. Independent of age, radiographic demonstration of thymic tissue was significantly associated with both a higher CD4(+) T cell count (P = 0.02) and a higher percentage and absolute number of circulating naive (CD45RA+CD62L+) CD4(+) T cells (P < 0.04). The prevalence of an abundant thymus was especially high in younger HIV-1-seropositive adults (</= 39 yr) with CD4 counts in the range 300-500 cells/microl and in older subjects (> 40 yr) regardless of CD4 count (P = 0.03). These studies suggest that the thymus is functional in some but not all adults with HIV-1 disease.

Entities:  

Mesh:

Year:  1998        PMID: 9616201      PMCID: PMC508819          DOI: 10.1172/JCI2834

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  61 in total

1.  Age involution in the normal human adult thymus.

Authors:  J G Simpson; E S Gray; J S Beck
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

2.  Thymic rebound in an adult following chemotherapy for testicular cancer.

Authors:  D M Tait; P Goldstraw; J E Husband
Journal:  Eur J Surg Oncol       Date:  1986-12       Impact factor: 4.424

3.  Neoplastic proliferation of the epithelium of the mammary lobules: adenosis, lobular neoplasia, and small cell carcinoma.

Authors:  C D Haagensen; N Lane; R Lattes
Journal:  Surg Clin North Am       Date:  1972-04       Impact factor: 2.741

4.  Lymphocyte differentiation and its microenvironment in the human thymus during aging.

Authors:  G G Steinmann; H K Müller-Hermelink
Journal:  Monogr Dev Biol       Date:  1984

5.  Age-related changes in the thymus gland: CT-pathologic correlation.

Authors:  A V Moore; M Korobkin; W Olanow; D K Heaston; P C Ram; N R Dunnick; P M Silverman
Journal:  AJR Am J Roentgenol       Date:  1983-08       Impact factor: 3.959

6.  Structural and functional alterations of the aging human thymus.

Authors:  H K Muller-Hermelink; G Steinmann; H Stein
Journal:  Adv Exp Med Biol       Date:  1982       Impact factor: 2.622

7.  Computed tomography of the normal thymus.

Authors:  R L Baron; J K Lee; S S Sagel; R R Peterson
Journal:  Radiology       Date:  1982-01       Impact factor: 11.105

8.  Influence of age of thymic grafts on the differentiation of T cells in nude mice.

Authors:  K Hirokawa; K Sato; T Makinodan
Journal:  Clin Immunol Immunopathol       Date:  1982-08

9.  Immunohistological demonstration of terminal transferase (TdT) in the age-involuted human thymus.

Authors:  G G Steinmann; H K Müller-Hermelink
Journal:  Immunobiology       Date:  1984-01       Impact factor: 3.144

10.  Precocious thymic involution manifest by epithelial injury in the acquired immune deficiency syndrome.

Authors:  T A Seemayer; A C Laroche; P Russo; R Malebranche; E Arnoux; J M Guérin; G Pierre; J M Dupuy; J G Gartner; W S Lapp
Journal:  Hum Pathol       Date:  1984-05       Impact factor: 3.466

View more
  54 in total

1.  The challenge of immune control of immunodeficiency virus.

Authors:  D Richman
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

2.  A simple relationship between viral load and survival time in HIV-1 infection.

Authors:  R A Arnaout; A L Lloyd; T R O'Brien; J J Goedert; J M Leonard; M A Nowak
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

3.  Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4+ and CD8+ lymphocyte apoptosis in HIV+ patients.

Authors:  L Caggiari; S Zanussi; M T Bortolin; M D'andrea; G Nasti; C Simonelli; U Tirelli; P De Paoli
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

4.  Functional reconstitution of thymopoiesis after human immunodeficiency virus infection.

Authors:  S G Kitchen; S Killian; J V Giorgi; J A Zack
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection.

Authors:  B F Haynes; L P Hale; K J Weinhold; D D Patel; H X Liao; P B Bressler; D M Jones; J F Demarest; K Gebhard-Mitchell; A T Haase; J A Bartlett
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

6.  Role of antiretroviral regimes in HIV-1 patients in reducing immune activation.

Authors:  Antonio Jiménez; Laura Molero; Ana Jiménez; Susana Castañón; Dolores Subirá; Miguel De Górgolas; Manuel Fedz-Guerrero; Rosa García
Journal:  Immunology       Date:  2002-05       Impact factor: 7.397

Review 7.  Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects.

Authors:  P De Paoli
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

8.  Immune Reconstitution Strategies in HIV.

Authors:  Matthew R. Leibowitz; Ronald T. Mitsuyasu
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

9.  Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope.

Authors:  Eric G Meissner; Karen M Duus; Feng Gao; Xiao-Fang Yu; Lishan Su
Journal:  Virology       Date:  2004-10-10       Impact factor: 3.616

10.  A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.

Authors:  Jeffrey M Jacobson; Hongying Wang; Rebeka Bordi; Lu Zheng; Barry H Gross; Alan L Landay; John Spritzler; Jean-Pierre Routy; Constance Benson; Judith Aberg; Pablo Tebas; David W Haas; Jennifer Tiu; Kristine Coughlin; Lynette Purdue; Rafick-Pierre Sekaly
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.